Answers are grounded in this paper and cite their sources.
The evidence shows a significant association between prolonged proton pump inhibitor use and an increased risk of hypomagnesemia. Clinicians should consider monitoring magnesium levels in patients receiving long-term PPI therapy.
No takes yet. Share an insight, caveat, or question.
Tripdatabase (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: